61 related articles for article (PubMed ID: 8740082)
1. Inhibition of lipid hydroperoxidation of low density lipoprotein by the Ca(2+)-channel and alpha 1-adrenoceptor antagonist monatepil maleate.
Hayashi K; Kuga Y; Nomura S; Okura Y; Tanaka K; Yasunobu Y; Nomura K; Shingu T; Kuwashima J; Kajiyama G
Arzneimittelforschung; 1996 Apr; 46(4):378-81. PubMed ID: 8740082
[TBL] [Abstract][Full Text] [Related]
2. Anti-atherosclerotic and plasma lipid lowering effects of the novel calcium blocker with alpha 1-adrenoceptor antagonistic activity, monatepil, in high cholesterol diet-fed Japanese Macaca fuscata monkeys.
Miyazaki M; Hosoki K; Okunishi H; Ishii K; Ikeno A; Okazaki Y
Arzneimittelforschung; 1994 Mar; 44(3):288-97. PubMed ID: 8192692
[TBL] [Abstract][Full Text] [Related]
3. Studies on calcium antagonistic and alpha 1-adrenergic receptor blocking activities of monatepil maleate, its metabolites and their enantiomers.
Honda Y; Masuda Y; Yoshida T; Sato F; Kurokawa M; Hosoki K
Arzneimittelforschung; 1995 Oct; 45(10):1057-60. PubMed ID: 8595057
[TBL] [Abstract][Full Text] [Related]
4. Relative contribution of alpha 1-adrenoceptor blocking activity to the hypotensive effect of the novel calcium antagonist monatepil.
Sugimoto T; Hosoki K; Karasawa T
J Cardiovasc Pharmacol; 1995 Jul; 26(1):55-60. PubMed ID: 7564365
[TBL] [Abstract][Full Text] [Related]
5. Effects of monatepil maleate, a new Ca2+ channel antagonist with alpha1-adrenoceptor antagonistic activity, on cholesterol absorption and catabolism in high cholesterol diet-fed rabbits.
Ikeno A; Sumiya T; Minato H; Fujitani B; Masuda Y; Hosoki K; Kurono M; Yasuba M
Jpn J Pharmacol; 1998 Nov; 78(3):303-12. PubMed ID: 9869264
[TBL] [Abstract][Full Text] [Related]
6. Antihypertensive, antiatherosclerotic, and plasma lipid-lowering effects of monatepil, a novel calcium antagonist with alpha 1-adrenoceptor-blocking activity in experimental animals.
Miyazaki M
Am J Hypertens; 1994 Oct; 7(10 Pt 2):131S-40S. PubMed ID: 7826563
[TBL] [Abstract][Full Text] [Related]
7. Effects of the new calcium antagonist monatepil on cardiac function and myocardial oxygen supply and demand in animals.
Kataoka T; Nose I; Honda Y; Yamada T; Hatano N; Masuda Y; Hosoki K; Karasawa T
Arzneimittelforschung; 1993 Dec; 43(12):1303-9. PubMed ID: 8141817
[TBL] [Abstract][Full Text] [Related]
8. In vitro and in vivo electrocardiographic evaluation of the novel calcium antagonist monatepil on cardiac conduction system.
Nose I; Kataoka T; Honda Y; Yamada T; Ikeno A; Fukuya F; Minato H; Takeyama K; Hosoki K; Karasawa T
Arzneimittelforschung; 1993 Jul; 43(7):722-8. PubMed ID: 8369002
[TBL] [Abstract][Full Text] [Related]
9. Antihypertensive effects of AJ-2615, a new calcium antagonist with alpha 1-adrenergic blocking activity in experimental hypertensive animals.
Ikeno A; Nose I; Fukuya F; Minato H; Takeyama K; Hosoki K; Karasawa T
J Cardiovasc Pharmacol; 1993 May; 21(5):815-21. PubMed ID: 7685454
[TBL] [Abstract][Full Text] [Related]
10. Effects of monatepil, a novel calcium antagonist with alpha 1-adrenergic blocking activity, on the low-density lipoprotein receptor in human skin fibroblasts.
Matsunaga A; Inoue T; Koga T; Mori K; Kugi M; Sasaki J; Arakawa K
Cardiovasc Drugs Ther; 1997 Dec; 11(6):747-50. PubMed ID: 9512869
[TBL] [Abstract][Full Text] [Related]
11. Effect of lipid peroxidation products and antioxidants on the formation of probucol radical in low density lipoproteins.
Shumaev KB; Ruuge EK; Dmitrovsky AA; Bykhovsky VYa ; Kukharchuk VV
Biochemistry (Mosc); 1997 Jun; 62(6):657-60. PubMed ID: 9284547
[TBL] [Abstract][Full Text] [Related]
12. Preventive effect of a new calcium antagonist, monatepil, on drug-induced ischaemic electrocardiographic changes in rats.
Yamamoto T; Nakatsuji K; Hosoki K; Karasawa T
Clin Exp Pharmacol Physiol; 1993 Nov; 20(11):673-8. PubMed ID: 8306512
[TBL] [Abstract][Full Text] [Related]
13. Apolipoprotein B carbonyl formation is enhanced by lipid peroxidation during copper-mediated oxidation of human low-density lipoproteins.
Yan LJ; Lodge JK; Traber MG; Packer L
Arch Biochem Biophys; 1997 Mar; 339(1):165-71. PubMed ID: 9056246
[TBL] [Abstract][Full Text] [Related]
14. Up-regulation of hepatic LDL receptor gene expression by monatepil, a novel calcium antagonist, in high cholesterol diet-fed Japanese monkeys.
Notake M; Kondo Y; Nomura H; Nakano K; Hosoki K; Miyazaki M
Am J Hypertens; 1994 Nov; 7(11):1026-30. PubMed ID: 7848617
[TBL] [Abstract][Full Text] [Related]
15. Cerebrovascular selectivity and vasospasmolytic action of the novel calcium antagonist (+/-)-(E)-1-(3-fluoro-6, 11-dihydrodibenz[b,e]oxepin-11-yl)-4-(3-phenyl-2-propenyl)-piperazine dimaleate in isolated cerebral arteries of the rabbit and dog.
Minato H; Hashizume M; Masuda Y; Fujitani B; Hosoki K
Arzneimittelforschung; 1997 Apr; 47(4):339-46. PubMed ID: 9150852
[TBL] [Abstract][Full Text] [Related]
16. Inhibitory effect of monatepil maleate on acyl-CoA:cholesterol acyltransferase activity in the liver of cholesterol-fed Japanese monkeys.
Sumiya T; Ikeno A; Kato H; Fujitani B; Masuda Y; Hosoki K; Miyazaki M
Am J Hypertens; 1997 Jul; 10(7 Pt 1):779-85. PubMed ID: 9234833
[TBL] [Abstract][Full Text] [Related]
17. Antioxidant effect of probucol on RO2*/O2(*-)-induced peroxidation of human low-density lipoproteins.
Bonnefont-Rousselot D; Segaud C; Jore D; Delattre J; Gardès-Albert M
Radiat Res; 1999 Mar; 151(3):343-53. PubMed ID: 10073673
[TBL] [Abstract][Full Text] [Related]
18. Antiperoxidative actions of calcium antagonists and atherogenesis.
Henry PD
J Cardiovasc Pharmacol; 1991; 18 Suppl 1():S6-10. PubMed ID: 1723459
[TBL] [Abstract][Full Text] [Related]
19. Probucol inhibits lipid peroxidation of macrophage and affects its secretory properties.
Liu GX; Ou DM; Liu JH; Huang HL; Liao DF
Acta Pharmacol Sin; 2000 Jul; 21(7):637-40. PubMed ID: 11360673
[TBL] [Abstract][Full Text] [Related]
20. Cu(I) availability paradoxically antagonizes antioxidant consumption and lipid peroxidation during the initiation phase of copper-induced LDL oxidation.
Bagnati M; Bordone R; Perugini C; Cau C; Albano E; Bellomo G
Biochem Biophys Res Commun; 1998 Dec; 253(2):235-40. PubMed ID: 9878521
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
